iRay Group (688301.SS) has a MoatMap StockRank of 45/100 based on Quality (56/100), Value (17/100), and Momentum (59/100) factor scores. The current signal is HOLD. iRay Group produces X-ray flat panel detectors. While it has solid technology, it lacks a strong connection to our 18-month macro themes and faces intensifying domestic competition in China.
iRay Group is a leading manufacturer of digital X-ray flat panel detectors used in medical, dental, and industrial imaging. The company's competitive moat is established by its mastery of core detector technologies, including amorphous silicon and IGZO thin-film transistors, and its global scale. It is a dominant market leader in the digital X-ray component sector, supplying major global medical imaging OEMs.
| Price | $24.45 |
| Market Cap | $6.3B |
| P/E (TTM) | 54.39 |
| P/E (Forward) | 32.53 |
| Price/Book | 5.70 |
| Return on Equity | 11.6% |
| Return on Invested Capital | 6.6% |
| Debt/Equity | 68.55 |
| Gross Margin | 50.2% |
| Operating Margin | 32.9% |
| Revenue Growth | 42.5% |
| Dividend Yield | 0.4% |
| Free Cash Flow | $-23M |
iRay Group operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (China).